Yuyu Pharma Inc. (000220) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yuyu Pharma Inc. (000220:KRX), powered by AI.

Current Price
₩3,900
P/E Ratio
8.1
Market Cap
66.4B
Sector
Healthcare
What is the Yuyu Pharma Inc. stock price forecast?

Yuyu Pharma Inc. is currently trading at ₩3,900. View real-time AI analysis on Alpha Lenz.

What is Yuyu Pharma Inc. insider trading activity?

View the latest insider trading data for Yuyu Pharma Inc. on Alpha Lenz.

What is Yuyu Pharma Inc.'s P/E ratio?

Yuyu Pharma Inc.'s P/E ratio is 8.1.

Yuyu Pharma Inc.

KRX · 000220
₩3,900-60(-1.52%)Market closedKRX regular session 09:00–15:30 KST
Ask about Yuyu Pharma Inc.'s future dividend policy...
Alpha Chat Insight

Yuyu Pharma Inc. trades at a P/E of 8.1 (undervalued) with modest ROE of 6.4%.

Ask for details

Company Overview

Yuyu Pharma Inc. is a South Korean pharmaceutical company focused on the research, development, and commercialization of healthcare products. The company's primary function is to provide innovative medical solutions that address unmet needs across various therapeutic areas, including cardiovascular health, oncology, and nervous system disorders. Yuyu Pharma Inc. engages in developing both prescription drugs and over-the-counter medications, offering a diversified product portfolio that contributes to the healthcare sector's evolving landscape. The company's activities have a significant impact on the pharmaceutical supply chain, emphasizing advanced drug delivery systems and sustainable healthcare solutions. In the financial markets, Yuyu Pharma Inc. plays a critical role as a driver of innovation and growth within the biotechnology industry, reflecting the increasing global demand for effective healthcare interventions. Founded with a commitment to improving patient outcomes, Yuyu Pharma Inc. continues to invest in cutting-edge research and strategic collaborations, underscoring its significance and competitive stance in the global pharmaceutical market.

CEO유원상, 박노용(각자대표)
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees254

Company Statistics

FY 2025

Profile

₩66,426,168,900Market Cap
₩140,884,666,970Revenue
17.03MShares Out
254Employees

Margins

38.29%Gross
12.10%EBITDA
7.82%Operating
6.73%Pre-Tax
6.47%Net

Valuation

8.15P/E
0.51P/B
0.47EV/Sales
4.47EV/EBITDA
8.95P/FCF

Growth (CAGR)

0.48%Rev 3Yr
7.50%Rev 5Yr
N/AOp Inc 3Yr
11.93%Op Inc 5Yr
N/ANet Inc 3Yr
30.46%Net Inc 5Yr

Returns

4.39%ROA
6.40%ROE
5.77%ROIC

Financial Health

₩29,090,832,970Cash & Cash Equivalents
₩37,588,392,430Net Debt
47.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Yuyu Pharma Inc. (ticker: 000220) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 254 employees. Market cap is $66.4B.

The current price is ₩3,900 with a P/E ratio of 8.15x and P/B of 0.51x.

ROE is 6.40% and operating margin is 7.82%. Annual revenue is $140.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Yuyu Pharma Inc. (000220) Stock Forecast 2026 ₩3,900 — Price, Financials & Analyst Targets | Alpha Lenz